241 related articles for article (PubMed ID: 25588677)
1. Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality.
Goel R; Ness PM; Takemoto CM; Krishnamurti L; King KE; Tobian AA
Blood; 2015 Feb; 125(9):1470-6. PubMed ID: 25588677
[TBL] [Abstract][Full Text] [Related]
2. Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012.
Goel R; King KE; Takemoto CM; Ness PM; Tobian AA
Transfusion; 2016 Jun; 56(6):1451-8. PubMed ID: 27079482
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusion practices in immune thrombocytopenia related hospitalizations.
Goel R; Chopra S; Tobian AAR; Ness PM; Frank SM; Cushing M; Vasovic L; Kaicker S; Takemoto C; Josephson CD; Nellis M; Bussel J; Krishnamurti L
Transfusion; 2019 Jan; 59(1):169-176. PubMed ID: 30520045
[TBL] [Abstract][Full Text] [Related]
4. Predictors of In-Hospital Mortality in Thrombotic Thrombocytopenic Purpura in Children in the United States: A Population Analysis.
Umapathi KK; Thavamani A; Puliyel M
J Pediatr Hematol Oncol; 2020 Jul; 42(5):e340-e344. PubMed ID: 32011563
[TBL] [Abstract][Full Text] [Related]
5. Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.
Chehab O; Abdallah N; Kanj A; Pahuja M; Adegbala O; Morsi RZ; Mishra T; Afonso L; Abidov A
Clin Cardiol; 2020 Jan; 43(1):50-59. PubMed ID: 31710764
[TBL] [Abstract][Full Text] [Related]
6. Platelet transfusion in thrombotic thrombocytopenic purpura.
Otrock ZK; Liu C; Grossman BJ
Vox Sang; 2015 Aug; 109(2):168-72. PubMed ID: 25900398
[TBL] [Abstract][Full Text] [Related]
7. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.
Khorana AA; Francis CW; Blumberg N; Culakova E; Refaai MA; Lyman GH
Arch Intern Med; 2008 Nov; 168(21):2377-81. PubMed ID: 19029504
[TBL] [Abstract][Full Text] [Related]
8. Predictors of in-hospital mortality and acute myocardial infarction in thrombotic thrombocytopenic purpura.
Balasubramaniyam N; Kolte D; Palaniswamy C; Yalamanchili K; Aronow WS; McClung JA; Khera S; Sule S; Peterson SJ; Frishman WH
Am J Med; 2013 Nov; 126(11):1016.e1-7. PubMed ID: 23993262
[TBL] [Abstract][Full Text] [Related]
9. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
Drews RE
Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura.
Swisher KK; Terrell DR; Vesely SK; Kremer Hovinga JA; Lämmle B; George JN
Transfusion; 2009 May; 49(5):873-87. PubMed ID: 19210323
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.
Ruggeri M; Tosetto A; Palandri F; Polverelli N; Mazzucconi MG; Santoro C; Gaidano G; Lunghi M; Zaja F; De Stefano V; Sartori R; Fazi P; Rodeghiero F;
J Thromb Haemost; 2014 Aug; 12(8):1266-73. PubMed ID: 24942752
[TBL] [Abstract][Full Text] [Related]
12. The Association Between Human Leukocyte Antigens and ITP, TTP, and HIT.
Amin Asnafi A; Jalali MT; Pezeshki SMS; Jaseb K; Saki N
J Pediatr Hematol Oncol; 2019 Mar; 41(2):81-86. PubMed ID: 30543580
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome.
Beneke J; Sartison A; Kielstein JT; Haller H; Nitschke M; Kunzendorf U; Loos S; Kemper MJ; Stahl RA; Menne J;
Transfus Med Rev; 2017 Jan; 31(1):51-55. PubMed ID: 27468945
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytopenic conditions-autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS.
Kravitz MS; Shoenfeld Y
Am J Hematol; 2005 Nov; 80(3):232-42. PubMed ID: 16247748
[TBL] [Abstract][Full Text] [Related]
15. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura.
Danese MD; Lindquist K; Gleeson M; Deuson R; Mikhael J
Am J Hematol; 2009 Oct; 84(10):631-5. PubMed ID: 19705429
[TBL] [Abstract][Full Text] [Related]
16. Platelet Transfusions in the PICU: Does Disease Severity Matter?
Saini A; West AN; Harrell C; Jones TL; Nellis ME; Joshi AD; Cowan KM; Gatewood CW; Ryder AB; Reiss UM
Pediatr Crit Care Med; 2018 Sep; 19(9):e472-e478. PubMed ID: 29927877
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of thrombotic events in patients with immune thrombocytopenia.
Ito S; Fujiwara SI; Ikeda T; Toda Y; Mashima K; Umino K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Yamamoto C; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Ann Hematol; 2020 Jan; 99(1):49-55. PubMed ID: 31853702
[TBL] [Abstract][Full Text] [Related]
18. Hematologic disorders.
Harrington W
Vox Sang; 1986; 51 Suppl 2():18-21. PubMed ID: 3765548
[TBL] [Abstract][Full Text] [Related]
19. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.
Abdelgawwad MS; Cao W; Zheng L; Kocher NK; Williams LA; Zheng XL
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235
[TBL] [Abstract][Full Text] [Related]
20. Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012.
An R; Wang PP
Vasc Health Risk Manag; 2017; 13():15-21. PubMed ID: 28176930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
